| Title |
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2003
|
| DOI | 10.1002/14651858.cd004000 |
| Pubmed ID | |
| Authors |
Richmal M Oates-Whitehead, J Harry Baumer, Linda Haines, Samantha Love, Ian K Maconochie, Amit Gupta, Kevin Roman, Jaspal S Dua, Ichiko Flynn |
| Abstract |
Kawasaki disease is the most common cause of acquired heart disease in children in developed countries. The coronary arteries supplying the heart can be damaged in Kawasaki disease. The principal advantage of timely diagnosis is the potential to prevent this complication with early treatment. Intravenous immunoglobulin (IVIG) is widely used for this purpose. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 146 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 22 | 15% |
| Researcher | 21 | 14% |
| Student > Master | 17 | 11% |
| Student > Bachelor | 14 | 9% |
| Student > Ph. D. Student | 11 | 7% |
| Other | 31 | 21% |
| Unknown | 32 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 74 | 50% |
| Nursing and Health Professions | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Immunology and Microbiology | 2 | 1% |
| Other | 14 | 9% |
| Unknown | 44 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 112. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#375,501
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#642
of 11,842 outputs
Outputs of similar age
#286
of 56,332 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 37 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 56,332 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.